Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upArndt Vogel, Erika Martinelli, Andrés Cervantes et al.|Annals of Oncology|2018Cited by 1.1k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Olga Barajas et al.|The Lancet|2023Cited by 1k
Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic CancerEric Van Cutsem, Malcolm J. Moore, Walter L. Vervenne et al.|Journal of Clinical Oncology|2009Cited by 643
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failureWim Laleman, Frederik Nevens, Alexander Wilmer et al.|Critical Care|2006Cited by 249
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Céline Piedvache, L. Chiche et al.|The Lancet|2024Cited by 153